Jack Jones

Cooley advised Clubessential Holdings, a global provider of software as a service and embedded payments solutions for membership-based organizations, backed by Battery Ventures and Silver Lake, on its definitive agreement to merge with Xplor Technologies, a platform providing software and embedded payments solutions to businesses in everyday life verticals, such as childcare and education, fitness and wellbeing, field services, and personal services.

Cooley advised Uber Technologies (NYSE: UBER), a technology platform that uses a massive network, leading technology, operational excellence and product expertise to power movement from point A to point B, on its $2.25 billion investment-grade bond offering.

Cooley advised Medicxi and other venture capital investors in Sanofi’s $1.6 billion acquisition of Vicebio, a biopharmaceutical company that develops novel vaccines against life-threatening respiratory viral infections.

Cooley advised EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, on its definitive agreement to be acquired by AstraZeneca (London Stock Exchange/Nasdaq Stockholm/Nasdaq: AZN) for up to $1 billion on a cash- and debt-free basis.

Cooley advised PetLab Co., a rapidly growing independent pet supplement brand headquartered in London, on its majority stake sale to BC Partners, a top international investment firm.